HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: bjsm.2007.035162v1 41/12/874    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by von Bueren, A. O Articles by Lichtensteiger, W. Search for Related Content PubMed PubMed Citation Articles by von Bueren, A. O Articles by Lichtensteiger, W. Topic Collections Relevant Article

Salbutamol exhibits androgenic activity in vitro

Institute of Pharmacology and Toxicology, University of Zurich, Switzerland

Correspondence to:
André O von Bueren, University Children’s Hospital, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland; Andre.vonBueren{at}kispi.uzh.ch

Background: Salbutamol has been shown to mediate anabolic effects after intravenous administration. However, the mechanism responsible for the anabolic actions of salbutamol remains unknown.

Aim: To investigate the potential mechanism by which salbutamol mediates anabolic effects in vitro.

Methods: The potential androgenic activity of salbutamol was investigated in vitro by the A-Screen assay that measures androgen-dependent inhibition of proliferation of the androgen receptor (AR)-positive human mammary carcinoma cell line, MCF7-AR1.

Results: The assay was validated with three known androgens; methyltrienolone (R1881), 5-dihydrotestosterone (DHT) and danazol. IC₅₀ values of R1881, DHT and danazol, 4.41x10^–11, 4.44x10^–11 and 1.08x10^–8 M, respectively, were in the ranges known from earlier studies. Our results demonstrate that salbutamol exhibits androgenic activity, with an IC₅₀ value of 8.93x10^–6 M. Anti-estrogenic or cytotoxic effects, which might have interfered with the assay, were excluded by additional experiments on wild-type MCF7 and MCF7-AR1 cells, respectively.

Conclusion: These data indicate that salbutamol exerts anabolic effects through androgen receptor agonistic activity in vitro.

Abbreviations: AR, androgen receptor; CD-FBS, charcoal–dextran treated foetal bovine serum; DHT, 5-dihydrotestosterone; OD, optical density; SRB, sulforhodamine B; TCA, trichloroacetic acid

Relevant Article

Commentary on "Salbutamol exhibits androgenic activity in vitro"

Katia Collomp
Br. J. Sports Med. 2007 41: 878. [Extract] [Full Text] [PDF]